Your session is about to expire
← Back to Search
1 for Type 1 Diabetes
Study Summary
This trial is testing if naloxone, given through the nose, will help preserve the body's response to low blood sugar the next day in people with type 1 diabetes.
- Type 1 Diabetes
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 4 trial • 570 Patients • NCT02032433Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Why is Naloxone given to patients so often?
"Naloxone is most frequently used as an antidote for opioid overdoses. However, it can also be given to relieve symptoms like pain, itching, and septic shock."
Could I possibly qualify to take part in this research?
"Currently, this clinical trial has 36 open slots for patients that have diabetes and an autoimmune disease. To be eligible, participants must also fall between the ages of 18-65."
Does this trial have an age limit?
"Eligibility for this particular clinical trial requires that patients are aged 18 to 65. However, if the patient does not meet these age requirements, there are still 168 trials and 247 trials respectively that might be a better fit."
Are there other examples of Naloxone being used in a clinical setting?
"As of now, there are 41 Naloxone studies that are ongoing with 10 in Phase 3. Out of the 126 study locations for Naloxone, several are based in Durham, North carolina."
Is there a potential for Naloxone to be harmful?
"There is some data suggesting that Naloxone is safe, but none to support that it is effective. It received a score of 2."
How many volunteers are taking part in this research?
"The listed trial is no longer recruiting patients. The initial posting was on September 18th, 2017 with the most recent edit on June 20th, 2022. There are presently 426 trials actively enrolling patients with diabetes and 41 for Naloxone that are still recruiting participants."
Are currently-enrolled patients being sought for this research?
"This trial is not currently looking for new participants. The study was first posted on September 18th, 2017 and was last updated on June 20th, 2022. If you are interested in other studies, there are 426 clinical trials actively recruiting participants with diabetes and 41 studies for Naloxone that are currently looking for patients."
Share this study with friends
Copy Link
Messenger